1. Eastell R. Pathogenesis of postmenopausal osteoporosis.

Primer on the
th

metabolic bone diseases and disorders of mineral metabolism. 5 edition.

Ed MJ Favus. AmericanSociety for Bone and Mineral Research 2003,
314-316
2. Eastell R, Bainbridge PR. Laboratory assessment of skeletal status. Atlas
of osteoporosis, second edition. Ed ES Orwoll, Series Ed SG Korenman.
Current Medicine Inc, Philadelphia 2003, 77-82.
3. Eastell R. Management of osteoporosis due to ovarian failure. Med Pediatr
Oncol 2003, Sep 41(3):222-7.
4. Eastell R, Adams J. Bone mineral density and bone markers subprotocol.
History and advancement of Anastrozole in the treatment of breast cancer.
Eds A Buzdar and M Baum. The Royal Society of Medicine Press 2003,
71-75.
5. Hannon RA, Eastell R. Biochemical markers of bone turnover and fracture
prediction. Journal of British Menopause Society, March 2003, 10-14.
6. Eastell R. Osteoporosis. Oxford Text Book of Endocrinology and Diabetes.
Eds. JAH Wass, SM Shalet, Oxford University Press, 2002, 665-675.
7. Eastell R, Bainbridge PR. Bone turnover markers: Their place in the
investigation of osteoporosis. Contemporary Endocrinology: Osteoporosis:
Pathophysiology and Clinical Management. Eds ES Orwoll, M Bliziotes.
Human Press Inc, Totowa NJ. 2002, 185-197.
8. Eastell R, Lambert H. Strategies for skeletal health in the elderly.
Proceedings of the Nutrition Society 2002, 61:173-180
9. Eastell R, Lambert H. Diet and healthy bones. Calcified Tissue International
2002; 70:400-4.
10. Vesper HW, Demers LM, Eastell R, Garnero P, Kleerekoper M, Robins
SP, Srivastava AK, Warnick GR, Watts NB, Myers GL. Related articles
assessment and recommendations on factors contributing to preanalytical
variability of urinary pyridinoline and deoxypyridinoline. Clinical Chemistry
2002, vol 48, 2:220-235.
11. Eastell R, Hart S. Bone turnover markers in clinical practice. Biomarkers of
disease: An evidence-based approach, 2002. Eds AK Trull, LM Demers,
DW Holt, A Johnston, JM Tredger, CP Price. Cambridge University Press.

12. Seibel MJ, Eastell R, Gundberg CM, Hannon R, Pols HAP. Biochemical markers
of bone metabolism. Principles of Bone Biology, second edition, vol 2, 2002. Eds
JP Bilezikian, LG Raisz, GA Rodan. Academic Press. 1543-1571.
13. Eastell R. Osteoporosis. Medicine 2001; 29:12:66-70.
14. Eastell R. Effects of inhaled steroids on bone mineral density: are the conclusions
misleading? IBMS BoneKey 2001, Nov 30 10.1138/ibmske;2001044.
15. Eastell R, Reid DM, Compston J et al. Secondary prevention of osteoporosis:
When should a non-vertebral fracture be a trigger for action? Quarterly Journal of
Medicine 2001, 94:575-597.
16. Eastell R. Risedronate: A new bisphosphonate for the prevention and treatment of
osteoporosis. Clinical Geriatrics 2001, vol 9, 12:36-46.
17. Clowes JA, Peel N, Eastell R. Glucocorticoid-induced osteoporosis. Current
Opinion in Rheumatology, 2001. Lippincott Williams & Wilkins Inc. 326-332.
18. Smith CM, Coombs RC, Eastell R. Effect of nutrient intake on markers of bone
turnover in preterm infants. Nutritional Aspects of Osteoporosis, 2001. Ed P
Burckhardt, Academic Press. 43-48.
19. Lambert H, Barker M, Eastell R. Calcium and bone mineral accretion in teenage
girls: a review. Nutritional Aspects of Osteoporosis, 2001. Ed P Burckhardt,
Academic Press, 23-32.
20. Eastell R. Definitions and interpretation of bone mineral density in a clinical
context. Manual of bone densitometry measurements. Ed JN Fordham, SpringerVerlag 2001,
21. Eastell R, Bainbridge PR. Bone turnover markers for monitoring antiresorptive
therapy. Osteoporosis Review 2001, vol 9:1;1-5.
22. Pereda CA, Eastell R. Calcium supplements alone and in association with
antiresorptive drugs in osteoporosis. Primary and Secondary Preventive Nutrition
2001, Eds A Bendich and RJ Deckelbaum, Humana Press Inc, Totowa NJ. 307321.
23. Delmas PD, Eastell R, Garnero P et al. The use of biochemical markers of bone
turnover in osteoporosis. Osteoporosis International 2000, suppl 6:S2-17.
24. Eastell R. Risedronate: Review of efficacy and safety in postmenopausal and
glucocorticoid-induced osteoporosis. Osteologia Osteology 2000, vol 3:4;314317.

25. Hannon R, Eastell R. Preanalytical variability of biochemical markers of bone

turnover. Osteoporosis International 2000, suppl 6:S30-44.
26. Clowes JA, Eastell R. The role of bone turnover markers and risk factors in the
assessment of osteoporosis and fracture risk. Bailliere's Clin Endo & Metab 2000,
vol 14, 2:213-232.
27. Lee AJ, Hodges S, Eastell R. Measurement of osteocalcin. Annals of Clinical
Biochemistry 2000, vol 37, 432-446.
28. Ingle BM, Eastell R. Ultrasound in clinical Practice. Quantitative Ultrasound:
Assessment of osteoporosis and bone status 1999. Eds. CF Njeh, D Hans, T
Fuerst, CC Gluer, HK Genant.Martin Dunitz, London. 325-336.
29. Eastell R, Naylor KE. Calcium homeostasis in pregnancy. Cherry and Merkatz's
Complications of pregnancy. Fifth edition. Ed W R Cohen 1999. Lippincott
Williams & Wilkins, Philadelphia. 451-463.
30. Eastell R, Hannon R.A. Biochemical markers of bone turnover. Treatment of the
postmenopausal woman: Basic and clinical aspects. Second edition. Eds Rogerio
A Lobo 1999. Lippincott Williams & Wilkins, Philadelphia. 293-303.
31. Meunier P, Delmas P, Eastell R et al. International Committee for Osteoporosis
Clinical Guidelines. Diagnosis and Management of osteoporosis in
postmenopausal women: Clinical Guidelines. Clinical Therapeutics 1999,
21(6):1025-1044.
32. Hart SM, Eastell R. Biochemical markers of bone turnover. Current Opinion in
Nephrology and Hypertension 1999, vol 8; 421-427.
33. Eastell R. Optimising the benefits of hormone replacement therapy for
osteoporosis. J Br Meno Soc 1999, vol 5, supplement 1:20-23.
34. Eastell R. Biochemical markers of bone turnover in Pagets disease of bone. Bone
1999, vol 24;5:49S-50S.
35. Eastell R, Machado ABC. Clinical application of biochemical markers of bone
turnover in osteoporosis. CME Bulletin Endocrinology & Diabetes 1999, vol 2;
1:4-6.
36. Eastell R, Reid DM, Compston J, et al. A UK Consensus Group on management
of glucocorticoid-induced osteoporosis: an update. J Int Med 1998, 244:271292.47.
37. Eastell R, Whybro A, Jagger H, Barker ME. Adaptation to young men to high
phosphate intake. Serono Symposia USA, Nutritional Aspects of Osteoporosis.

Eds P Burckhardt, B Dawson-Hughes, R Heaney, 1998 Springer-Verlag New

York, Inc. p185-190.
38. Jones N, Lambert HL, Eastell R, Barker ME. Bone growth in childhood and
adolewcence: the interpretation of dietary supplementation trials. Serono
Symposia USA, Nutritional Aspects of Osteoporosis. Eds P Burckhardt, B
Dawson-Hughes, R Heaney, 1998 Springer-Verlag New York, Inc. p50-55.
39. 43. Hannon R, Eastell R. Bone metabolism and osteoporosis. J Br Meno Soc
1998, vol 4, 3:103-106.
40. Eastell R. Treatment of postmenopausal osteoporosis. The New England Journal
of Medicine 1998, vol 338: 11;736-746.
41. Eastell R, Peel N. Osteoporosis. Journal of the Royal College of Physicians of
London 1998, vol 32; 1:14-18.
42. Eastell R, Boyle IT, Compston J et al. Management of male osteoporosis: report
of the UK Consensus Group. Quarterly Journal of Medicine 1998; 91: 71-92.
43. Eastell R, Riggs B L. Vitamin D and Osteoporosis. Vitamin D, Eds Feldman D,
Glorieux FH, Pike JW. Academic Press, USA. 1997, 695-711.
44. Blumsohn A, Eastell R. The performance and utility of biochemical markers of
bone turnover: do we know enough to use them in clinical practice? Ann Clin
Biochem 1997; 34: 449-459.
45. Eastell R, Blumsohn A. The value of biochemical markers of bone turnover in
osteoporosis. J Rheum 1997, vol 24; 6:1215-1217.
46. Eastell R. Osteoporosis. The Medicine Group (Journals) 1997, vol 25; 76-80.
47. Seibel MJ, Baylink DJ, Farley JR, Epstein S, Yamauchi M, Eastell R, Pols HAP,
Raisz LG, Gundberg CM. Basic science and clinical utility of biochemical
markers of bone turnover - A congress report. Exp Clin Endocrinol Diabetes
1997, vol 105; 125-133.
48. Vinholes J, Coleman R, Eastell R. Effects of bone metastases on bone
metabolism: implications for diagnosis, imaging and assessment of response to
cancer treatment. Cancer Treatment Reviews 1996, vol 22; 289-331.
49. Eastell R, Devogelaer JP, Peel NFA, Gill C, Bax DE, Nagant de Deuxchaisnes C,
Russell RGG. A double-blind placebo-controlled study to determine the effects of
risedronate on bone loss in glucocorticoid-treated rheumatoid arthritis.
Proceedings of the 1996 World Congress on Osteoporosis. Osteoporosis 1996,
391-393.

50. 32. Eastell R. Assessment of bone density and bone loss. Osteoporosis Int 1996,
Suppl 2:S3-S5.
51. Eastell, R. Workshop Session V. Management of corticosteroid-induced
osteoporosis. Osteoporosis Int 1996, Suppl 2:S36-S37.
52. Eastell R. Forearm Fracture. Bone 1996; Vol 18, 3:203S-207S (Supplement).
53. Eastell R, Blumsohn A. New tests for the assessment of bone turnover in
osteoporosis. Proceedings UK NEQAS Meeting l994. Endocrine Aspects of the
Menopause, 87-93.
54. Eastell R. Determination of bone resorption. Kinetic Models of Trace Element
and Mineral Metabolism during Development. Eds Siva Subramanian KN,
Wastney ME, CRC Press, 1995, 355-358.
55. Eastell R. Management of corticosteroid-induced osteoporosis. J Int Med, 1995;
237: 439-447.
56. Hannon RA, Eastell R. Biochemical markers of bone turnover. The Measurement
of Metabolic Bone Disease, Tovey FI, Stamp TCB, eds. Parthenon Publishing,
Carnforth, 1995, 21-47.
57. Blumsohn A, Hannon RA, Eastell R.. Biochemical assessment of skeletal activity.
Physical Medicine and Rehabilitation Clinics of North America, 1995, Vol 6,
3:483-505.
58. Blumsohn A, Eastell R. Age-related factors (in bone loss). Osteoporosis:
Etiology, diagnosis and management, second edition , Riggs BL, Melton LJ, eds.
Raven Press, New York, Osteoporosis: Etiology, Diagnosis and Management
1995, 161-182.
59. Peel NFA, Eastell R. Osteoporosis (ABC of Rheumatology). British Medical
Journal 1995, Vol 310:989-992.
60. Evans C, Eastell R. Adaptation to high dietary sodium intake. Challenges of
Modern Medicine 1995, Vol 7: 413-418.
61. Blumsohn A, Eastell R. Calcium supplementation and circadian rhythms of bone
turnover. Challenges of Modern Medicine 1995, Vol 7: 273-277.
62. Eastell R. Biochemical Markers. Spine: State of the Art Reviews 1994; 8: 155170.
63. Eastell R. Investigation of metabolic bone disease. Medicine International 1994,
Vol. 22: 190-194.

64. Eastell R: The role of calcium and exercise in the prevention of postmenopausal
osteoporosis. Journal of Obstetrics and Gynaecology 1993; 13:S5-S7.
65. Peel NFA, Eastell R. Measurement of bone mass and turnover. Baillieres Clinical
Rheumatology 1993, Vol. 7 3:479-498.
66. Russell RGG, Colwell A, Hannon RA, Blumsohn A, Al-Dehaimi AW, Assiri
AMA, Peel NFA, Eastell R. Biochemical measurements in pagets disease of bone.
Seminars in Arthritis and Rheumatism 1994, Vol 23 4:240-241.
67. 15. Cooper C, Eastell R. Bone gain and loss in premenopausal women. Br Med J
1993; 306:1357-1358.
68. Blumsohn A, Eastell R. Prediction of bone loss in postmenopausal women. Eur J
Clin Invest 1992; 22:764-766.
69. Peel NFA, Eastell R, Russell RGG. Markers of bone and collagen breakdown. In:
Emery P (Editor). Balliere's Clinical Rheumatology Management of early
inflammatory arthritis. Balliere Tindall, London 1992 6:351-372.
70. Peel NFA, Eastell R, Russell RGG. Osteoporosis in rheumatoid arthritis - The
laboratory perspective. British Journal of Rheumatology 1991; 30: 84-85.
71. Eastell R, Heath H III. The hypocalcemic states: differential diagnosis and
management. In: Coe FL, Favus MJ, eds. Disorders of Bone and Mineral
Metabolism. New York: Raven Press, 571-586.
72. Eastell R, Riggs BL. Diagnostic evaluation of osteoporosis (review). Endocrinol
Metab Clin North Am 1988; 17: 547-572.
73. 9. Eastell R, Heath H III, Kumar R, Riggs BL. Pathophysiology of osteoporosis.
Hormonal factors: PTH, vitamin D, and calcitonin. In: Riggs BL, Melton LJ III,
eds. Osteoporosis: Etiology, Diagnosis and Management. New York: Raven
Press, 1988; 373-388.
74. Eastell R, Hay ID. Metabolic considerations: hypercalcemia of malignancy. In:
Sim FH, ed. Diagnosis and Management of Metastatic Bone Disease: A
Multidisciplinary Approach. New York: Raven Press, 1988; 147-152.
75. Eastell R, Riggs BL. Endocrinology and aging: calcium metabolism and
osteoporosis (review). Endocrinol Metab Clin North Am 1987; 16: 829-842.
76. Eastell R, Riggs BL. New approaches to the treatment of osteoporosis (review).
Clin Obstet Gynecol 1987; 30: 860-870.

77. Eastell R, Riggs BL. Treatment of osteoporosis (review). Obstet Gynecol Clinics
N Amer 1987; 14: 77-88.
78. Eastell R, Riggs BL. Exercise, hypogonadism, and osteopenia (Editorial). J Am
Med Assoc 1986; 256: 392-393.
79. Wahner HW, Eastell R, Riggs BL. Bone mineral density of the radius: where do
we stand? (editorial) J Nucl Med 1985; 26: 1339-1341.
80. Smith MA, Tothill P, Kennedy NSJ, Eastell R. Total body calcium by neutron
activation analysis. Dixon AStJ, Russell RGG, Stamp TCB, eds. Osteoporosis, a
Multidisciplinary Problem. London: Academic Press, 1983; 121-125.
81. Smith MA, Eastell R, Kennedy NSJ, Nuki G, Reid DM, Strong JA, Tothill P. The
assessment of osteoporosis by neutron activation analysis. Menczel J, Robin GC,
Makin M, Steinberg R, eds. Osteoporosis. London: John Wiley and Sons, 1983;
45-48..
82. Peel N, Eastell R. Osteoporosis (ABC of Rheumatology). British Medical
Journal. 3rd edition. Ed ML Snaith. BMJ Publishing Group Limited, 2004 :4549.
83. Adhikari M, Morris BW, Eastell R, Blumsohn A. A placebo controlled
randomized trial of chromium picolinate supplementation on indices of bone and
calcium metabolism in healthy women. Nutritional Aspects of Osteoporosis. 2nd
edition. Elsevier Science, 2004:141-151.
84. Eastell R, Naylor KE, Cooper AM. Pathogenesis of transplantation bone disease:
A unifying hypothesis. Bone Disease of Organ Transplantation. Eds J Compston
and E Shane. Elsevier Academic Press 2005:209-217
85. Eastell R, Riggs BL. Vitamin D and Osteoporosis. Vitamin D, 2nd edition. Eds
D Feldman, J Wesley Pike, and F H Glorieux. Elsevier Academic Press 2005:
1101-1120
86. Eastell R. New management strategies for osteoporosis. Horizons in
Medicine 16.Ed. J Franklyn. Royal College of Physicians of London
2004:63-68